Scaling India’s Pharmaceutical Ecosystem: Strategic Shifts Toward R&D and Global Competitiveness

Furthermore, this policy trajectory reflects a broader vision of 'Atmanirbhar Bharat' in the health sector. By creating a conducive environment for innovation, the government intends to empower domestic firms to transition from 'copying' to 'creating,' which is essential for long-term sustainability. However, the success of these initiatives will depend on the seamless synergy between academia, industry, and regulatory bodies to ensure that the R&D output translates into commercially viable and globally accessible medical solutions. For India to sustain its growth, the focus must remain on bridging the gap between laboratory research and industrial-scale manufacturing, ensuring that the benefits of these parks permeate the entire pharmaceutical value chain. UPSC Relevance: This topic is highly relevant for GS Paper III under 'Industrial Policy' and 'Achievements of Indians in Science & Technology.' Aspirants can utilize this to discuss how government-led infrastructure interventions (like PLI schemes and industrial parks) act as catalysts for economic growth and import substitution in the health sector. It provides a strong case study for answering questions on the challenges of industrialization and the transition toward an innovation-led economy.